Rigel Pharmaceuticals reported $-14791000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Agenus AGEN:US $ -83.99M 29.59M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Applied Genetic Technologies AGTC:US $ -14.28M 0.52M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Celldex Therapeutics CLDX:US $ -13.37M 3.16M
Chemocentryx CCXI:US $ -39.21M 9.5M
Daiichi Sankyo 4568:JP Y 47062M 72506M
Dicerna Pharmaceuticals DRNA:US $ -40.27M 10.3M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Flexion Therapeutics FLXN:US $ -22208000 6.35M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Immunogen IMGN:US $ -30.74M 3.31M
Intrexon XON:US $ -20.12M 1.77M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Macrogenics MGNX:US $ -39.94M 11.34M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Rigel Pharmaceuticals RIGL:US $ -14.79M 56.06M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Veracyte VCYT:US $ 9.19M 19.75M